Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy (Q34188392)

31 July 2017

1 reference

title

Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy (English)

1 reference

31 July 2017

0 references

2

Harry L Malech

1 reference

31 July 2017

Sebastian Brenner

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Biochimica et Biophysica Acta

31 July 2017

published in

1 reference

31 July 2017

volume

1640

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-24

1 reference

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Foamy virus reverse transcriptase is expressed independently from the Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Integration of murine leukemia virus DNA depends on mitosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Simian virus 40 minichromosomes as targets for retroviral integration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

High-throughput retroviral tagging to identify components of specific signaling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

New genes involved in cancer identified by retroviral tagging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Position-effect variegation and the new biology of heterochromatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Stopped at the border: boundaries and insulators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A chromatin insulator protects retrovirus vectors from chromosomal position effects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

DNA methylation and chromatin modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Epigenetics: regulation through repression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Differential engraftment of genetically modified CD34(+) and CD34(-) hematopoietic cell subsets in lethally irradiated baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene therapy for adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Internal ribosome entry site biology and its use in expression vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

In vivo selection of retrovirally transduced hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Selection of keratinocytes transduced with the multidrug resistance gene in an in vitro skin model presents a strategy for enhancing gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Repair of telomeric DNA prior to replicative senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

In vivo selection using a cell-growth switch

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Pharmacologically regulated in vivo selection in a large animal

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

The RD114/simian type D retrovirus receptor is a neutral amino acid transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Identification of the block in targeted retroviral-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Ligand-directed retroviral targeting of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Progress toward vector design for hematopoietic stem cell gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Progress with retroviral gene vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A safe packaging line for gene transfer: separating viral genes on two different plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Development of a novel trans-lentiviral vector that affords predictable safety

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Correction of sickle cell disease in transgenic mouse models by gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentiviral vectors for enhanced gene expression in human hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentiviral gene transfer to the nonhuman primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Lentivirus vectors using human and simian immunodeficiency virus elements.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Stable gene transfer to the nervous system using a non-primate lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene transfer vectors derived from equine infectious anemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene transfer systems derived from Visna virus: analysis of virus production and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Restriction of lentivirus in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Restriction of multiple divergent retroviruses by Lv1 and Ref1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A dominant block to HIV-1 replication at reverse transcription in simian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Early replication block of human immunodeficiency virus type 1 in monkey cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

1 reference

7 January 2021

Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Kinetic analyses of stability of simple and complex retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Side effects of retroviral gene transfer into hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum-free versus serum-containing conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Use of Serum-Free Medium with Fibronectin Fragment Enhanced Transduction in a System of Gas Permeable Plastic Containers to Achieve High Levels of Retrovirus Transduction at Clinical Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Human gene marker/therapy clinical protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene transfer approaches to the lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

Safety considerations in vector development

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2803%2900024-7

7 January 2021

10.1016/S0167-4889(03)00024-7

Identifiers

DOI

1 reference

31 July 2017

1 reference